ATE429431T1 - 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren - Google Patents

2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren

Info

Publication number: ATE429431T1
Authority: AT; Austria
Prior art keywords: suphonamides; spectr; benzoxazole; broad; amino
Prior art date: 2001-05-11

Application number

AT02735354T

Other languages

German (de)

English (en)

Inventor

Dominique Surleraux

Sandrine Vendeville

Wim Verschueren

Bethune Marie-Pierre De

Kock Herman De

Abdellah Tahri

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-11

Filing date

2002-05-10

Publication date

2009-05-15

2002-05-10 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2009-05-15 Application granted granted Critical

2009-05-15 Publication of ATE429431T1 publication Critical patent/ATE429431T1/de

Links

JPBLHOJFMBOCAF-UHFFFAOYSA-N 1,3-benzoxazol-2-amine Chemical compound C1=CC=C2OC(N)=NC2=C1 JPBLHOJFMBOCAF-UHFFFAOYSA-N 0.000 title 1
239000004030 hiv protease inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

AT02735354T 2001-05-11 2002-05-10 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren ATE429431T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01201732		2001-05-11
PCT/EP2002/005212 WO2002092595A1 (en)	2001-05-11	2002-05-10	Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors

Publications (1)

Publication Number	Publication Date
ATE429431T1 true ATE429431T1 (de)	2009-05-15

Family

ID=8180286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02735354T ATE429431T1 (de)	2001-05-11	2002-05-10	2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren

Country Status (31)

Country	Link
US (2)	US7622490B2 (es)
EP (1)	EP1387842B1 (es)
JP (1)	JP4467889B2 (es)
KR (1)	KR100878853B1 (es)
CN (1)	CN100549007C (es)
AP (1)	AP1652A (es)
AR (1)	AR035970A1 (es)
AT (1)	ATE429431T1 (es)
AU (1)	AU2002310818B2 (es)
BG (1)	BG66350B1 (es)
BR (1)	BR0209594A (es)
CA (1)	CA2444895C (es)
CY (1)	CY1109247T1 (es)
CZ (1)	CZ304524B6 (es)
DE (1)	DE60232067D1 (es)
DK (1)	DK1387842T3 (es)
EA (1)	EA009590B1 (es)
EE (1)	EE05307B1 (es)
ES (1)	ES2325809T3 (es)
HR (1)	HRP20031026B1 (es)
HU (1)	HUP0400438A3 (es)
IL (1)	IL158093A0 (es)
MX (1)	MXPA03010258A (es)
NO (1)	NO326883B1 (es)
NZ (1)	NZ529250A (es)
OA (1)	OA13134A (es)
PL (1)	PL209029B1 (es)
PT (1)	PT1387842E (es)
SK (1)	SK287952B6 (es)
WO (1)	WO2002092595A1 (es)
ZA (1)	ZA200307799B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7364752B1 (en)	1999-11-12	2008-04-29	Abbott Laboratories	Solid dispersion pharamaceutical formulations
EP1175205B1 (en)	1999-11-12	2006-06-14	Abbott Laboratories	Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10026698A1 (de)	2000-05-30	2001-12-06	Basf Ag	Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7109230B2 (en)	2002-01-07	2006-09-19	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
US7157489B2 (en)	2002-03-12	2007-01-02	The Board Of Trustees Of The University Of Illinois	HIV protease inhibitors
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
WO2005030739A1 (en) *	2003-09-30	2005-04-07	Tibotec Pharmaceuticals Ltd.	Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
US8193227B2 (en)	2003-12-11	2012-06-05	Abbott Laboratories	HIV protease inhibiting compounds
US20050131042A1 (en) *	2003-12-11	2005-06-16	Flentge Charles A.	HIV protease inhibiting compounds
JP4818124B2 (ja)	2003-12-23	2011-11-16	テイボテク・フアーマシユーチカルズ・リミテツド	（３Ｒ，３ａＳ，６ａＲ）−ヘキサヒドロフロ〔２，３−ｂ〕フラン−３−イル（１Ｓ，１Ｒ）−３−〔〔（４−アミノフェニル）スルホニル〕（イソブチル）アミノ〕−１−ベンジル−２−ヒドロキシプロピルカルバマートの製造方法
KR101192859B1 (ko)	2003-12-23	2012-10-19	얀센 알 앤드 디 아일랜드	（3ｒ,3ａｓ,6ａｒ）-헥사하이드로푸로〔2,3-ｂ〕푸란-3-일（1ｓ,2ｒ）-3-〔〔（4-아미노페닐）설포닐〕（이소부틸）아미노〕-1-벤질-2-하이드록시프로필카바메이트의 제조방법
AU2005244121B2 (en) *	2004-05-07	2012-01-19	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
ES2331257T3 (es)	2005-02-25	2009-12-28	Tibotec Pharmaceuticals	Sintesis de precursores de inhibidores de proteasas.
AR053845A1 (es) *	2005-04-15	2007-05-23	Tibotec Pharm Ltd	5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
US20120220520A1 (en) *	2006-10-17	2012-08-30	Van T Klooster Gerben Albert Eleutherius	Bioavailable combinations for hcv treatment
WO2014194519A1 (en)	2013-06-07	2014-12-11	Merck Sharp & Dohme Corp.	Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8204879D0 (sv)	1982-08-26	1982-08-26	Haessle Ab	Novel chemical intermediates
DE69121436T2 (de)	1990-03-09	1997-01-09	Milliken Res Corp	Organische Materialien, die sulfonamidogebundene Poly(oxyalkylen)gruppen tragen und ihre Herstellung
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
CA2142998C (en) *	1992-08-25	2008-01-29	Michael L. Vazquez	N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors
PH30929A (en)	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
ES2127938T3 (es)	1993-08-24	1999-05-01	Searle & Co	Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
ES2166786T3 (es)	1993-10-01	2002-05-01	Astrazeneca Ab	Procedimiento i.
DE69637380T2 (de)	1995-01-20	2009-09-17	G.D. Searle Llc, Chicago	Bis-sulfonamid-hydroxyethylamino-derivate als inhibitoren retroviraler proteasen
US5756533A (en) *	1995-03-10	1998-05-26	G.D. Searle & Co.	Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
CN1149223C (zh)	1995-03-10	2004-05-12	G·D·瑟尔公司	杂环羰基氨基酸羟乙氨基磺酰胺逆转录病毒蛋白酶抑制剂
US6150556A (en) *	1995-03-10	2000-11-21	G. D. Dearle & Co.	Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) *	1995-03-10	1998-01-06	G.D. Searle & Co.	Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5753660A (en) *	1995-11-15	1998-05-19	G. D. Searle & Co.	Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6509038B2 (en)	1996-05-20	2003-01-21	Janssen Pharmaceutica N.V.	Antifungal compositions with improved bioavailability
CZ295502B6 (cs)	1997-03-26	2005-08-17	Janssen Pharmaceutica N. V.	Antifungální peleta, způsob její přípravy a farmaceutická dávková forma s obsahem těchto pelet
GB9717849D0 (en)	1997-08-23	1997-10-29	Seal Sands Chemicals Limited	Preparation of pyridene derivatives
EP1042280A2 (en)	1997-12-24	2000-10-11	Vertex Pharmaceuticals Incorporated	Prodrugs of aspartyl protease inhibitors
AU2010299A (en)	1997-12-24	1999-07-19	Vertex Pharmaceuticals Incorporated	Prodrugs os aspartyl protease inhibitors
US6436989B1 (en)	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
AU2012199A (en)	1997-12-24	1999-07-19	Vertex Pharmaceuticals Incorporated	Prodrugs of aspartyl protease inhibitors
AU4828199A (en)	1998-06-23	2000-01-10	Board Of Trustees Of The University Of Illinois, The	Multi-drug resistant retroviral protease inhibitors and associated methods
PT2336134T (pt)	1998-06-23	2016-10-19	The Board Of Trustees Of The Univ Of Illionis	Ensaio de aptidão e métodos para reduzir a resistência do hiv à terapia
EP1397367A2 (en) *	2001-04-09	2004-03-17	Tibotec Pharmaceuticals Ltd.	Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors

2002
- 2002-05-10 US US10/474,485 patent/US7622490B2/en not_active Expired - Fee Related
- 2002-05-10 EE EEP200300547A patent/EE05307B1/xx not_active IP Right Cessation
- 2002-05-10 CA CA2444895A patent/CA2444895C/en not_active Expired - Fee Related
- 2002-05-10 CZ CZ2003-3290A patent/CZ304524B6/cs not_active IP Right Cessation
- 2002-05-10 SK SK1490-2003A patent/SK287952B6/sk not_active IP Right Cessation
- 2002-05-10 EP EP02735354A patent/EP1387842B1/en not_active Expired - Lifetime
- 2002-05-10 AU AU2002310818A patent/AU2002310818B2/en not_active Ceased
- 2002-05-10 JP JP2002589479A patent/JP4467889B2/ja not_active Expired - Fee Related
- 2002-05-10 DE DE60232067T patent/DE60232067D1/de not_active Expired - Lifetime
- 2002-05-10 AT AT02735354T patent/ATE429431T1/de active
- 2002-05-10 ES ES02735354T patent/ES2325809T3/es not_active Expired - Lifetime
- 2002-05-10 NZ NZ529250A patent/NZ529250A/en not_active IP Right Cessation
- 2002-05-10 HU HU0400438A patent/HUP0400438A3/hu not_active IP Right Cessation
- 2002-05-10 HR HRP20031026AA patent/HRP20031026B1/xx not_active IP Right Cessation
- 2002-05-10 PL PL366780A patent/PL209029B1/pl unknown
- 2002-05-10 BR BR0209594-7A patent/BR0209594A/pt not_active IP Right Cessation
- 2002-05-10 PT PT02735354T patent/PT1387842E/pt unknown
- 2002-05-10 EA EA200301234A patent/EA009590B1/ru not_active IP Right Cessation
- 2002-05-10 KR KR1020037013145A patent/KR100878853B1/ko not_active Expired - Fee Related
- 2002-05-10 OA OA1200300277A patent/OA13134A/en unknown
- 2002-05-10 CN CNB028097416A patent/CN100549007C/zh not_active Expired - Fee Related
- 2002-05-10 DK DK02735354T patent/DK1387842T3/da active
- 2002-05-10 AP APAP/P/2003/002904A patent/AP1652A/en active
- 2002-05-10 MX MXPA03010258A patent/MXPA03010258A/es active IP Right Grant
- 2002-05-10 IL IL15809302A patent/IL158093A0/xx not_active IP Right Cessation
- 2002-05-10 WO PCT/EP2002/005212 patent/WO2002092595A1/en not_active Ceased
- 2002-05-10 AR ARP020101722A patent/AR035970A1/es active IP Right Grant
2003
- 2003-10-06 ZA ZA2003/07799A patent/ZA200307799B/en unknown
- 2003-11-03 BG BG108309A patent/BG66350B1/bg unknown
- 2003-11-10 NO NO20034988A patent/NO326883B1/no not_active IP Right Cessation
2009
- 2009-07-21 CY CY20091100774T patent/CY1109247T1/el unknown
- 2009-10-07 US US12/575,216 patent/US7863306B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BG66350B1 (bg)	2013-08-30
CN1507446A (zh)	2004-06-23
IL158093A0 (en)	2004-03-28
EA200301234A1 (ru)	2004-04-29
US20040106661A1 (en)	2004-06-03
ES2325809T3 (es)	2009-09-18
HRP20031026A2 (en)	2005-10-31
CZ304524B6 (cs)	2014-06-18
MXPA03010258A (es)	2005-03-07
CN100549007C (zh)	2009-10-14
AR035970A1 (es)	2004-07-28
EE05307B1 (et)	2010-06-15
EA009590B1 (ru)	2008-02-28
US7863306B2 (en)	2011-01-04
DK1387842T3 (da)	2009-08-10
JP4467889B2 (ja)	2010-05-26
OA13134A (en)	2006-12-13
HUP0400438A2 (hu)	2004-08-30
AP1652A (en)	2006-08-11
EE200300547A (et)	2004-02-16
KR100878853B1 (ko)	2009-01-15
NO20034988D0 (no)	2003-11-10
PT1387842E (pt)	2009-07-20
NZ529250A (en)	2005-05-27
CA2444895A1 (en)	2002-11-21
CA2444895C (en)	2011-02-15
CY1109247T1 (el)	2014-07-02
DE60232067D1 (de)	2009-06-04
PL366780A1 (en)	2005-02-07
WO2002092595A1 (en)	2002-11-21
US20100029632A1 (en)	2010-02-04
ZA200307799B (en)	2005-03-30
HRP20031026B1 (hr)	2012-07-31
EP1387842A1 (en)	2004-02-11
NO326883B1 (no)	2009-03-09
BR0209594A (pt)	2004-03-30
JP2004534757A (ja)	2004-11-18
SK14902003A3 (sk)	2004-07-07
AP2003002904A0 (en)	2003-12-31
KR20040022417A (ko)	2004-03-12
HK1062912A1 (en)	2004-12-03
SK287952B6 (sk)	2012-06-04
HUP0400438A3 (en)	2007-08-28
AU2002310818B2 (en)	2007-12-13
EP1387842B1 (en)	2009-04-22
US7622490B2 (en)	2009-11-24
BG108309A (bg)	2004-12-30
PL209029B1 (pl)	2011-07-29
CZ20033290A3 (cs)	2004-05-12

Legal Events

Date

Code

Title

Description

2009-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1387842

Country of ref document: EP

Publication	Publication Date	Title
CY2012007I1 (el)	2014-07-02	Πεπτιδομιμητικοι αναστολεις πρωτεασης
ATE397925T1 (de)	2008-07-15	Cis-imidazoline als mdm2-hemmer
DE60234125D1 (de)	2009-12-03	E inhibitoren
CY2015028I2 (el)	2016-07-27	Ενας αναστολεας ν-ακυλοσφιγγοσινο γλυκοζυλοτρανσφερασης
NO20034042D0 (no)	2003-09-12	Metallproteinase-inhibitorer
PT1370553E (pt)	2006-09-29	Inibidores de rhoquinase
DE60218138D1 (de)	2007-03-29	Rho-kinase inhibitoren
EE200300439A (et)	2003-12-15	Metalloproteinaasi inhibiitorid
EP1499336A4 (en)	2005-06-01	PROTEASE INHIBITORS
NO20034032L (no)	2003-11-10	Metallproteinase-inhibitorer
DE60215623D1 (de)	2006-12-07	Breitspektrum 2-(substituierte-amino)-benzothiazol-sulfonamide hiv protease inhibitoren
DK1458447T3 (da)	2010-01-18	Kombination af cytokrom-p450-beroende proteasinhibitorer
IS7305A (is)	2004-06-10	HIV-integrasa tálmar
DE60232067D1 (de)	2009-06-04	2-amino-benzoxazol-suphonamide als breitspektrum-hiv-protease-inhibitoren
NO20025786D0 (no)	2002-12-02	Protaseinhibitorer
NO20043114L (no)	2004-09-20	Bredspektrede heterocyklisk substituerte fenylinneholdende sulfonamid-HIV-proteaseinhibitorer
NO20025005D0 (no)	2002-10-17	Proteaseinhibitorer
EP1463521A4 (en)	2009-06-24	GP41 INHIBITORS
NO20013535L (no)	2002-09-09	Nöytrofil-funksjons-inhibitorer
NO20032328D0 (no)	2003-05-22	Proteaseinhibitorer
EP1427439A4 (en)	2004-11-17	GAMMA-THREE PROTEASE
DE60204623D1 (de)	2005-07-21	Inhibitor-Schalteranordnung
AU2003287325A8 (en)	2004-06-03	N-cycloalkylglycines as hiv protease inhibitors
ATE270267T1 (de)	2004-07-15	Scyphostatin-analoga als smase-inhibitoren
DOP2001000307A (es)	2002-11-30	Inhibidores de thrombin